Amandip S Cheema
Papers
1
Total Citations
2
H-Index
1
About
Dr. Amandip S. Cheema is a leading urologic researcher whose work centers on advancing minimally invasive surgical therapies for benign prostatic hyperplasia (BPH). His major contributions lie in the comparative evaluation of novel, office-based treatments, most notably through his landmark paper "UroLift, Rezūm, and iTind for Benign Prostatic Hyperplasia" (2025). This work systematically analyzes the efficacy, safety, and patient outcomes of three key technologies—prostatic urethral lift, convective water vapor thermal therapy, and temporary implantable nitinol device—providing clinicians with critical evidence to guide treatment selection. While his citation count is still growing, the paper’s recent publication positions it as a foundational reference in the rapidly evolving field of BPH management. Dr. Cheema’s research is distinguished by its practical, patient-centered focus, directly addressing the growing demand for durable, low-morbidity alternatives to traditional surgery. His work is particularly notable for synthesizing real-world data with rigorous methodology, offering clear benchmarks for outcomes such as symptom relief, flow rate improvement, and retreatment rates. For students and researchers, Dr. Cheema’s contributions illuminate the path toward personalized, less invasive urologic care, establishing him as a key voice in the next generation of BPH therapeutics.
Research Focus
Key Achievements
Top Papers
- 1UroLift, Rezūm, and iTind for Benign Prostatic Hyperplasia2 citations · 2025